Patient assistance
Free help paying for rare disease medications.
mendmeds tracks 12 rare disease medications, with 24 active assistance programs, each linked to its official source with the date we checked it.
Browse
Every rare disease medication we cover
- Austedo (deutetrabenazine)2 active programsTypically around $8,500 per month without assistance
- Bkemv (eculizumab-aeeb)1 active program
- Creon (pancrelipase)Medicare options2 active programsTypically around $2,500 per month without assistance
- Ekterly (sebetralstat)3 active programs
- Epysqli (eculizumab-aagh)1 active program
- Hemlibra (emicizumab-kxwh)2 active programsTypically around $21,000 per month without assistance
- Imaavy (nipocalimab-aahu)Medicare options3 active programs
- Ingrezza (valbenazine)2 active programsTypically around $8,500 per month without assistance
- Soliris (eculizumab)Medicare options2 active programs
- Trikafta (elexacaftor / tezacaftor / ivacaftor)2 active programsTypically around $26,500 per month without assistance
- Ultomiris (ravulizumab-cwvz)2 active programs
- Vyndamax (tafamidis)Medicare options2 active programs